The NeoRhea study is a phase 2 clinical trial that focuses on patients with...
Genomic signatures have shown promise in predicting the pathological complete...
The standard treatment for hormone receptor-positive HER2-negative advanced...
Exciting preliminary results from the LUMINANCE study were presented at the...
Dr. Pierre van Mol from the KU Leuven Laboratory for Translational Genetics...
At ELCC 2023, Louise Berteloot from the Innovation Centre RADar at the AZ Delta...
At ELCC 2023, Marc Terrones from the University of Antwerp presented his...
Dr Monica Cejuela, a medical oncologist from the Virgen del Rocio Hospital at...
Dr Mattia Rediti, medical oncologist and PhD student at the Breast Cancer...
Dr Maja Van Goistenhoven, a gynaecologist in formation at the KULeuven,...